Zobrazeno 1 - 10 of 39 pro vyhledávání: '"Edward M Kloza"'
1
Assessment of a Simplified Cell-Free DNA Method for Prenatal Down Syndrome Screening
Autor: Glenn E Palomaki, Elizabeth E Eklund, Edward M Kloza, Geralyn M Lambert-Messerlian
Publikováno v: Clinical Chemistry. 68:1449-1458
Background Prenatal screening for common trisomies via cell-free (cfDNA) is usually implemented by technologies utilizing massively parallel sequencing, stringent environmental controls, complex bioinformatics, and molecular expertise. An alternative
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d2866d2a0bb031685e78614bcf15d62
https://doi.org/10.1093/clinchem/hvac131
Zobrazit plný text záznamu
3
Prenatal cell-free DNA screening test failures: a systematic review of failure rates, risks of Down syndrome, and impact of repeat testing
Autor: Edward M. Kloza, Glenn E. Palomaki
Publikováno v: Genetics in Medicine. 20:1312-1323
We systematically reviewed the published literature on test failure rates for the sequencing of cell-free DNA (cfDNA) in maternal plasma to identify Down syndrome. We searched peer-reviewed English publications with diagnostic results on all pregnanc
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9beb4df6c0fc950b43d0dbf904657e72
https://doi.org/10.1038/gim.2018.22
Zobrazit plný text záznamu
4
The clinical utility of DNA-based screening for fetal aneuploidy by primary obstetrical care providers in the general pregnancy population
Autor: Edward M. Kloza, Elizabeth E. Eklund, Barbara O'Brien, Glenn E. Palomaki, Geralyn Lambert-Messerlian
Publikováno v: Genetics in Medicine
Objective: To assess the clinical utility of cell-free DNA (cfDNA)-based screening for aneuploidies offered through primary obstetrical care providers to a general pregnancy population. Methods: Patient educational materials were developed and valida
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d705576166f9445cfa688843335699ea
https://doi.org/10.1038/gim.2016.194
Zobrazit plný text záznamu
7
Evaluation of Patient Education Materials: The Example of Circulating cell free DNA Testing for Aneuploidy
Autor: Jacquelyn V. Halliday, Paula K. Haddow, Geralyn Lambert-Messerlian, Edward M. Kloza, Barbara O'Brien, Glenn E. Palomaki
Publikováno v: Journal of Genetic Counseling. 24:259-266
Informed consent is the process by which the treating health care provider discloses appropriate information to a competent patient so that the patient may make a voluntary choice to accept or refuse treatment. When the analysis of circulating cell f
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::878c460f19bebd804a4bccb45403d998
https://doi.org/10.1007/s10897-014-9758-8
Zobrazit plný text záznamu
8
Maternal plasma DNA testing for aneuploidy in pregnancies achieved by assisted reproductive technologies
Autor: Jaroslav Loucky, Cosmin Deciu, Dirk van den Boom, Maurice J. Mahoney, Pierangela De Biasio, Allan T. Bombard, John Williams, Edward M. Kloza, Mathias Ehrich, Geralyn Lambert-Messerlian, Louise Wilkins-Haug, Barbara O'Brien, Antoni Borrell, Glenn E. Palomaki
Publikováno v: Genetics in Medicine. 16:419-422
We sought to compare measurements of circulating cell-free DNA as well as Down syndrome test results in women with naturally conceived pregnancies with those conceived using assisted reproductive technologies.Data regarding assisted reproductive tech
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::798a9d739549ea9c17af6291247a49f5
https://doi.org/10.1038/gim.2013.149
Zobrazit plný text záznamu
9
The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies
Autor: Jacob A. Canick, Geralyn Lambert-Messerlian, Glenn E. Palomaki, James E. Haddow, Edward M. Kloza
Publikováno v: Prenatal Diagnosis. 33:667-674
Maternal plasma contains circulating cell-free DNA fragments originating from both the mother and the placenta. The proportion derived from the placenta is known as the fetal fraction. When measured between 10 and 20 gestational weeks, the average fe
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4d974b200cea59542c8b5564f54f11ae
https://doi.org/10.1002/pd.4126
Zobrazit plný text záznamu
10
DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations
Autor: Mathias Ehrich, Allan T. Bombard, Geralyn Lambert-Messerlian, Glenn E. Palomaki, Edward M. Kloza, James E. Haddow, Cosmin Deciu, Jacob A. Canick, Dirk van den Boom
Publikováno v: Prenatal Diagnosis. 32:730-734
Objective Studies on prenatal testing for Down syndrome (trisomy 21), trisomy 18, and trisomy 13 by massively parallel shotgun sequencing (MPSS) of circulating cell free DNA have been, for the most part, limited to singleton pregnancies. If MPSS test
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9725906d55a2e03d6f643ac67d683855
https://doi.org/10.1002/pd.3892
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje